Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
SODIUM CHLORIDE
Bausch & Lomb UK Limited
S01AX03
SODIUM CHLORIDE
0.9 %w/v
Eye Drops Solution
Product not subject to medical prescription
zinc compounds
Marketed
1983-04-01
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Minims Saline 0.9% w/v Eye Drops, Solution. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Sodium Chloride 0.9% w/v. For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Eye drops, solution Single use, clear, colourless, sterile eye drops, solution 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS As a topical ocular irrigating solution. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Adults (including the elderly) and Children: Adequate solution should be used to irrigate the eye. 4.3 CONTRAINDICATIONS None. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE None. 4.5 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION None known. 4.6 FERTILITY, PREGNANCY AND LACTATION Not applicable. 4.7 EFFECTS ON ABILITY TO DRIVE AND USE MACHINES None known. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _0_ _5_ _/_ _1_ _2_ _/_ _2_ _0_ _1_ _4_ _C_ _R_ _N_ _ _ _2_ _1_ _5_ _4_ _6_ _3_ _7_ _p_ _a_ _g_ _e_ _ _ _n_ _u_ _m_ _b_ _e_ _r_ _:_ _ _ _1_ 4.8 UNDESIRABLE EFFECTS None known. 4.9 OVERDOSE Not applicable. 5 PHARMACOLOGICAL PROPERTIES 5.1 PHARMACODYNAMIC PROPERTIES Minims Saline is an isotonic solution of sodium chloride used for irrigation of the eye. There are no pharmacodynamic properties of relevance for this product. 5.2 PHARMACOKINETIC PROPERTIES There are no pharmacokinetic properties which are applicable for this product. 5.3 PRECLINICAL SAFETY DATA There are no preclinical data of relevance to the Read the complete document